Author:
Natalicchio Annalisa,De Stefano Francesca,Perrini Sebastio,Laviola Luigi,Cignarelli Angelo,Caccioppoli Cristina,Quagliara Anna,Melchiorre Mariangela,Leonardini Anna,Conserva Antonella,Giorgino Francesco
Abstract
The p66Shcprotein isoform regulates MAP kinase activity and the actin cytoskeleton turnover, which are both required for normal glucose transport responses. To investigate the role of p66Shcin glucose transport regulation in skeletal muscle cells, L6 myoblasts with antisense-mediated reduction (L6/p66Shcas) or adenovirus-mediated overexpression (L6/p66Shcadv) of the p66Shcprotein were examined. L6/Shcas myoblasts showed constitutive activation of ERK-1/2 and disruption of the actin network, associated with an 11-fold increase in basal glucose transport. GLUT1 and GLUT3 transporter proteins were sevenfold and fourfold more abundant, respectively, and were localized throughout the cytoplasm. Conversely, in L6 myoblasts overexpressing p66Shc, basal glucose uptake rates were reduced by 30% in parallel with a ∼50% reduction in total GLUT1 and GLUT3 transporter levels. Inhibition of the increased ERK-1/2 activity with PD98059 in L6/Shcas cells had a minimal effect on increased GLUT1 and GLUT3 protein levels, but restored the actin cytoskeleton, and reduced the abnormally high basal glucose uptake by 70%. In conclusion, p66Shcappears to regulate the glucose transport system in skeletal muscle myoblasts by controlling, via MAP kinase, the integrity of the actin cytoskeleton and by modulating cellular expression of GLUT1 and GLUT3 transporter proteins via ERK-independent pathways.
Publisher
American Physiological Society
Subject
Physiology (medical),Physiology,Endocrinology, Diabetes and Metabolism
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献